We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 25, 2016

Eribulin in Patients With Metastatic Breast Cancer With at Least One Prior Chemotherapy

Annals of Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Oncology
Pooled Analyses of Eribulin in Metastatic Breast Cancer Patients With at Least 1 Prior Chemotherapy
Ann. Oncol 2016 May 13;[EPub Ahead of Print], X Pivot, F Marmé, R Koenigsberg, M Guo, E Berrak, A Wolfer

Further Reading